Author

Michelle L. Boytim

Observed names: M. Boytim, M. L. Boytim, Michelle Boytim

Institutions: Amsterdam UMC Location University of Amsterdam, Cancer Prevention Pharmaceuticals (United States), Amsterdam University Medical Centers, University of Amsterdam

Observed institutions: Fox Chase Cancer Center, University of Michigan, Amsterdam UMC Location University of Amsterdam, Virginia Oncology Associates, Cancer Prevention Pharmaceuticals (United States), Amsterdam University Medical Centers, Arizona Oncology, University of Arizona Cancer Center, University of Amsterdam

OpenAlex ID: A5033005694

A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer

2009 · Stacy Moulder, Navneet Dhillon, et al. · Investigational New Drugs · 35

Combination of Sulindac and Eflornithine Delays the Need for Lower Gastrointestinal Surgery in Patients With Familial Adenomatous Polyposis: Post Hoc Analysis of a Randomized Clinical Trial

2021 · Francesc Balaguer, Elena M. Stoffel, et al. · Diseases of the Colon & Rectum · 21

A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

2009 · Steven J. Cohen, Mark M. Zalupski, et al. · Cancer Chemotherapy and Pharmacology · 20

A phase I study of imexon inj plus gemcitabine as first-line therapy for advanced pancreatic cancer with preclinical mechanistic study of dose limiting toxicity

2008 · S. J. Cohen, M. M. Zalupski, et al. · Journal of Clinical Oncology · 2

Radiofrequency Tonsil Reduction

2001 · Lionel M. Nelson, Michelle L. Boytim · Archives of Otolaryngology - Head and Neck Surgery · 2

A phase I study of imexon in combination with docetaxel (DOC) for the treatment of patients with breast, lung and prostate cancer

2008 · S. L. Moulder, N. Dhillon, et al. · Journal of Clinical Oncology · 1

S0266 Sulindac and Eflornithine Combination Delays the Need for Lower Gastrointestinal Surgery in Familial Adenomatous Polyposis: CPP FAP-310 Trial

2020 · Francesc Balaguer, Elena Stoffel, et al. · The American Journal of Gastroenterology

Phase I trial of imexon, Inj. plus gemcitabine in patients with advanced previously untreated pancreatic adenocarcinoma

2007 · S. J. Cohen, M. Zalupski, et al. · Journal of Clinical Oncology

Effect of saline on temperature-controlled radio-frequency ablation

2002 · Michelle L. Boytim, Gregory M. Kosanovich, et al. · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE

Works count: 9

Citation count: 81

H-index: 3

I10-index: 3